WG3. Molecular genetics: guidelines for genomics and functional genomic diagnostics

The objective of WG3 is to improve molecular diagnosing of MCD patients, by improving the analysis of genetic data and identify the most cost-effective tests. An important task of WG3 will be the implementation of NGS into diagnostics, comparison of different techniques and the interpretation of its data, especially unclassified and/or rare variants in both known and novel MCD genes, and to explore functional tests to support variant interpretation. WG3 will form a bridge from the clinic and the diagnostic laboratories to basic scientists and v.v. WG3 will provide suggestions for future research to WG5 and it will reach out to NGS companies.

WG3 aims:

  • Improve molecular diagnostics of MCD patients
  • Develop standardized workflow and best practice guidelines for the molecular genetic diagnosis of malformations of cortical development
  • Explore functional tests to support variant interpretation
  • Establish a variant interpretation review panel


Working Group 3 members: Stavit Allon-Shalev, Eleonora Aronica, Stefan Barakat, Nathalie Boddaert, Ivan Capo, Carlos Cardoso,Valerio Conti, Julie DésirNataliya DiDonato, Elena Domínguez Garrido, Fiona Francis, Renzo Guerrini,Andreas Christian Hade, Dragana Josifova,Hülya Kayserili,Andreas Kremer, Kerstin Kutsche, Ghayda Mirzaa, Deborah Morris-Rosendahl, Sara Nuovo, Elena Parrini, Corin Charles Sammut, Ana Maria Sánchez Pérez, Katrien Stouffs, Enza Maria Valente, Luis M. Valor, Martina Wilke, Maha Zaki


Back to Working Groups.